Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas – a single centre experience
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Montoto S, Corradini P, Dreyling M, Ghielmini M, Kimby E, López-Guillermo A, et al. Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Hematologica 2013; 98: 1014-21.MontotoSCorradiniPDreylingMGhielminiMKimbyELópez-GuillermoAIndications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working PartyHematologica20139810142110.3324/haematol.2013.084723369660323813647Search in Google Scholar
Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447-52.FisherRILeBlancMPressOWMaloneyDGUngerJMMillerTPNew treatment options have changed the survival of patients with follicular lymphomaJ Clin Oncol20052384475210.1200/JCO.2005.03.167416230674Search in Google Scholar
Bachy E, Houot R, Morschhauser F, Sonet A, Brice P, Belhadj K, et al. Longterm follow up of the FL2000 study comparing CHVP-interferon to CHVP interferon plus rituximab infollicular lymphoma. Hematologica 2013; 98: 1107-14.BachyEHouotRMorschhauserFSonetABricePBelhadjKLongterm follow up of the FL2000 study comparing CHVP-interferon to CHVP interferon plus rituximab infollicular lymphomaHematologica20139811071410.3324/haematol.2012.082412369661523645690Search in Google Scholar
Vidal L, Gafter-Gvili A, Salles G, Dreyling MH, Ghielmini M, Hsu Schmitz SF, et al. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 2011; 103: 1799-806.VidalLGafter-GviliASallesGDreylingMHGhielminiMHsu SchmitzSFRituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trialsJ Natl Cancer Inst2011103179980610.1093/jnci/djr41822021664Search in Google Scholar
Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Cochrane Database Syst Rev 2012; 1: CD007678 10.1002/14651858.SchaafMReiserMBorchmannPEngertASkoetzNHigh-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adultsCochrane Database Syst Rev20121CD00767810.1002/14651858Open DOISearch in Google Scholar
Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnsen HE, et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918-27.SchoutenHCQianWKvaloySPorcelliniAHagbergHJohnsenHEHigh-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trialJ Clin Oncol20032139182710.1200/JCO.2003.10.02314517188Search in Google Scholar
Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, et al. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma. Br J Haematol 2008; 141: 235-43.IngramWDevereuxSDas-GuptaEPRussellNHHaynesAPByrneJLOutcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaBr J Haematol20081412354310.1111/j.1365-2141.2008.07067.x18318762Search in Google Scholar
Robinson SP, Canals C, Luang JJ, Tilly H, Crawley C, Cahn JY, et al. The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplant 2013; 48: 1409-14.RobinsonSPCanalsCLuangJJTillyHCrawleyCCahnJYThe outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTBone Marrow Transplant20134814091410.1038/bmt.2013.8323771004Search in Google Scholar
van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003; 102: 3521-9.van BesienKLoberizaFRJrBajorunaiteRArmitageJOBasheyABurnsLJComparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaBlood20031023521910.1182/blood-2003-04-120512893748Search in Google Scholar
Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, et al. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. Biol Blood Marrow Transplant 2011; 17: 1051-7.TomblynMREwellMBredesonCKahlBSGoodmanSAHorowitzMMAutologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseBiol Blood Marrow Transplant2011171051710.1016/j.bbmt.2010.11.004311427221073974Search in Google Scholar
Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677-84.DreylingMLenzGHosterE, Van HoofAGisselbrechtCSchmitsREarly consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkBlood200510526778410.1182/blood-2004-10-388315591112Search in Google Scholar
Witzig TE. Current treatment approaches for mantle-cell lymphoma. J Clin Oncol 2005; 23: 6409-14.WitzigTECurrent treatment approaches for mantle-cell lymphomaJ Clin Oncol20052364091410.1200/JCO.2005.55.01716155027Search in Google Scholar
Merli F, Luminari S, Ilariucci F, Petrini M, Visco C, Ambrosetti A, et al. Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi. Br J Haematol 2012; 156: 346-53.MerliFLuminariSIlariucciFPetriniMViscoCAmbrosettiARituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiBr J Haematol20121563465310.1111/j.1365-2141.2011.08958.x22145911Search in Google Scholar
Iams W, Reddy MN. Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective. Ther Adv Hematol 2014; 5: 153-67.IamsWReddyMNConsolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveTher Adv Hematol201451536710.1177/2040620714547327419909125324956Search in Google Scholar
Delarue R, Haioun C, Ribrag V, Brice P, Delmer A, Tilly H, et al. CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d’Etude des Lymphomes de l’Adulte. Blood 2013; 121: 48-53.DelarueRHaiounCRibragVBricePDelmerATillyHCHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d’Etude des Lymphomes de l’AdulteBlood2013121485310.1182/blood-2011-09-37032022718839Search in Google Scholar
Lunning MA, Armitage JO. The place of transplantation in mantle cell lymphoma. Oncology 2013; 27: 2-6.LunningMAArmitageJOThe place of transplantation in mantle cell lymphomaOncology20132726Search in Google Scholar
Lenz G, Dreyling M, Schiegnitz E, Haferlach T, Hasford J, Unterhalt M, et al. Moderate increase of secondary hematologic malignancies following myeloablative radiochemotherapy and autologous stem cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 2004; 22: 4926-33.LenzGDreylingMSchiegnitzEHaferlachTHasfordJUnterhaltMModerate increase of secondary hematologic malignancies following myeloablative radiochemotherapy and autologous stem cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)J Clin Oncol20042249263310.1200/JCO.2004.06.01615611507Search in Google Scholar
Bhatt VR, Vose JM. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma. Hematol Oncol Clin North Am 2014; 28: 1073-95.BhattVRVoseJMHematopoietic stem cell transplantation for non-Hodgkin lymphomaHematol Oncol Clin North Am20142810739510.1016/j.hoc.2014.08.01525459180Search in Google Scholar
Romaguera JE, Fayad LE, Feng L, Hartig K, Weaver P, Rodriguez MA, et al. Ten-year follow-up after intense chemoimmunotherapy with RituximabHyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma. Br J Haematol 2010; 150: 200-8.RomagueraJEFayadLEFengLHartigKWeaverPRodriguezMATen-year follow-up after intense chemoimmunotherapy with RituximabHyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphomaBr J Haematol20101502008Search in Google Scholar
Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, et al. ESMO Guidelines Working Group. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25: 83-92.DreylingMGeislerCHermineOKluin-NelemansHCLe GouillSRuleSESMO Guidelines Working Group. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201425839210.1093/annonc/mdu26425210087Search in Google Scholar
Pettengell R, Schmitz N, Gisselbrecht C, Smith G, Patton WN, Metzner B, et al. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2013; 31: 1624-30.PettengellRSchmitzNGisselbrechtCSmithGPattonWNMetznerBRituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationJ Clin Oncol20133116243010.1200/JCO.2012.47.186223547078Search in Google Scholar
Cheson BD, Pfistner D, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-86.ChesonBDPfistnerDJuweidMEGascoyneRDSpechtLHorningSJRevised response criteria for malignant lymphomaJ Clin Oncol2007255798610.1200/JCO.2006.09.240317242396Search in Google Scholar
El-Najjar I, Boumendil A, Luan JJ, Bouabdallah R, Thomson K, Mohty M, et al. The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party. Ann Oncol 2014; 25: 2224-9.El-NajjarIBoumendilALuanJJBouabdallahRThomsonKMohtyMThe impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working PartyAnn Oncol2014252224910.1093/annonc/mdu44025193988Search in Google Scholar
Khouri IF, Saliba RM, Erwin WD, Samuels BI, Korbling M, Medeiros LJ, et al. Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results. Blood 2012; 119: 6373-8.KhouriIFSalibaRMErwinWDSamuelsBIKorblingMMedeirosLJNonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsBlood20121196373810.1182/blood-2012-03-417808434730622586182Search in Google Scholar
Sebban C, Mounier N, Brousse N, Belanger C, Brice P, Haioun C, et al. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d’Etude des Lymphomes de l’Adulte (GELA). Blood 2006; 108: 2540-4.SebbanCMounierNBrousseNBelangerCBricePHaiounCStandard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d’Etude des Lymphomes de l’Adulte (GELA)Blood20061082540410.1182/blood-2006-03-01319316835383Search in Google Scholar
Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: longterm follow-up. J Clin Oncol 2007; 25: 2554-9.RohatinerAZNadlerLDaviesAJApostolidisJNeubergDMatthewsJMyeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: longterm follow-upJ Clin Oncol2007252554910.1200/JCO.2006.09.832717515573Search in Google Scholar
Le Gouill S, De Guibert S, Planche L, Brice P, Dupuis J, Cartron G, et al. Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study. Hematologica 2011; 96: 1128-35.Le GouillSDe GuibertSPlancheLBricePDupuisJCartronGImpact of the use of autologous stem cell transplantation at first relapse both in na- ïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studyHematologica20119611283510.3324/haematol.2010.030320314890621486862Search in Google Scholar
Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, et al. Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. J Clin Oncol 2009; 27: 6101-8.DamonLEJohnsonJLNiedzwieckiDChesonBDHurdDDBartlettNLImmunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909J Clin Oncol2009276101810.1200/JCO.2009.22.2554279303219917845Search in Google Scholar
Szcześniak M, Armatys A, Kurzawa R, Kandzia T, KoziołD, Frankiewicz A, et al. Autologous stem cell transplantation for mantle cell lymphoma – single centre experience. Contemp Oncol (Pozn) 2013; 17: 456-9.SzcześniakMArmatysAKurzawaRKandziaTKoziołD, FrankiewiczAAutologous stem cell transplantation for mantle cell lymphoma – single centre experienceContemp Oncol (Pozn)201317456910.5114/wo.2013.37223393403024596536Search in Google Scholar
Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 2008; 112: 2687-93.GeislerCHKolstadALaurellAAndersenNSPedersenLBJerkemanMLong-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma GroupBlood200811226879310.1182/blood-2008-03-147025255660618625886Search in Google Scholar
Oinonen R, Jantunen E, Itälä M, Lehtinen T, Kuittinen O, Franssila K, et al. Autologous stem cell transplantation in patients with mantle cell lymphoma. Leuk Lymphoma 2002; 43: 1229-37.OinonenRJantunenEItäläMLehtinenTKuittinenOFranssilaKAutologous stem cell transplantation in patients with mantle cell lymphomaLeuk Lymphoma20024312293710.1080/1042819029002628612152990Search in Google Scholar
Dreger P, Martin S, Kuse R, Sonnen R, Glass B, Kröger N, et al. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients. Hematol J 2000; 1: 87-94.DregerPMartinSKuseRSonnenRGlassBKrögerNThe impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patientsHematol J20001879410.1038/sj.thj.620000711920175Search in Google Scholar
Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947-55.MicallefINLillingtonDMApostolidisJAmessJANeatMMatthewsJTherapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignanciesJ Clin Oncol2000189475510.1200/JCO.2000.18.5.94710694543Search in Google Scholar
Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicentre case-control study. Blood 2003; 101: 2015-23.MetayerCCurtisREVoseJSobocinskiKAHorowitzMMBhatiaSMyelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicentre case-control studyBlood200310120152310.1182/blood-2002-04-126112393427Search in Google Scholar
Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, et al. Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biol Ther 2013; 14: 1077-88.AkhtariMBhattVRTandraPKKrishnamurthyJHorstmanHDreessenATherapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patientsCancer Biol Ther20131410778810.4161/cbt.26342391202924025414Search in Google Scholar
